Director/Sr. Director – Women’s Health, Osteoporosis,
Eli Lilly and Company · Indianapolis, IN · 2 wk ago
Management$164k–$282k/yrFull-time
About the role
The Senior Director – Osteoporosis, Women’s Health position at Lilly is seeking an experienced discovery leader to help build a portfolio of transformative therapies to improve outcomes for women everywhere and arrest age-related functional decline across genders. This role offers the opportunity to shape strategy, drive impactful drug discovery and development programs, and contribute to Lilly’s mission of scientific excellence and patient-centered care.
Key Responsibilities
- Build and lead an innovative lab focused on novel approaches to identify and validate targets/pathways for osteoporosis.
- Bring novel, high potential targets into the pipeline for therapeutic approaches for the treatment of osteoporosis.
- Define and implement the preclinical discovery strategy for osteoporosis, including target discovery, validation and prioritization frameworks, experimental approaches, and decision criteria.
- Drive portfolio prioritization, articulating differentiation, risk, and alignment with clinical and regulatory expectations.
- Build and evolve preclinical and translational capabilities (internal and external) to support execution of the strategy.
- Identify and shape external opportunities, including academic collaborations, CRO partnerships, and business development opportunities.
- Ensure alignment of osteoporosis strategy with broader Women’s Health and musculoskeletal portfolio objectives.
- Lead osteoporosis discovery programs, driving target identification, validation, and progression of therapeutic candidates.
- Design and implement end-to-end experimental strategies across in vitro, ex vivo, and in vivo systems.
- Generate decision-enabling data to support program advancement and portfolio decisions.
- Define and implement translational approaches linking mechanisms to clinical outcomes, including biomarker strategies and PK/PD relationships.
- Ensure preclinical programs are designed to enable clear clinical differentiation, incorporating relevant endpoints such as bone density, bone strength, and microarchitecture.
- Serve as biology lead on cross-functional teams, partnering closely with colleagues across function.
- Influence decision-making and problem-solving to accelerate program progression.
- Lead and manage strategic collaborations with CROs and academic partners.
- Maintain scientific leadership through publications, presentations, and external engagement in osteoporosis and skeletal biology.
- Directly recruit and supervise scientists and provide mentoring, performance management and career development.
Qualifications
- Ph.D. in a relevant subject area
- Minimum of 10 years of relevant experience in academia, industry or related field
Additional Preferences
- Deep expertise in osteoporosis and skeletal biology, including bone remodeling
- 10 years' experience after post doc training
- Demonstrated success in drug discovery, from target identification through preclinical development
- Proven track record of shaping discovery strategy and influencing portfolio decisions
- Strong experience with preclinical in vitro, ex vivo, and in vivo models for osteoporosis
- Experience building new capabilities, platforms, or external collaborations
- Strong cross-functional leadership and scientific communication skills
- Passion for advancing innovative therapies addressing unmet needs in women’s health